SCHEMBL740545

SCHEMBL740545

COc1ccccc1C(C)(C)NC(=O)c1cc2c(NC(=O)c3ccc(CN4CCCCC4)cc3)n[nH]c2s1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.60
BCR P11274 2/20 0.60
KDR P35968 1/20 0.46
CYP2C9 P11712 1/20 0.44
HRH3 Q9Y5N1 2/20 0.42
LMNA P02545 5/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MAPT P10636 3/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 2/20 0.41
HSD17B10 Q99714 2/20 0.41
USP2 O75604 1/20 0.41
AURKA O14965 1/20 0.41
FGFR1 P11362 1/20 0.40
KMT2A Q03164 1/20 0.40
KDM4E B2RXH2 3/20 0.40
TP53 P04637 1/20 0.40
TSHR P16473 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL740797 0.99 ABL1 (0.59) ABL1BCRKDRCYP2C9HRH3
SCHEMBL742316 0.98 ABL1 (0.57) ABL1BCRKDRCYP2C9HRH3
SCHEMBL740827 0.93 ABL1 (0.51) ABL1BCRKDRLMNASMN1; SMN2
SCHEMBL2431018 0.90 ABL1 (0.62) ABL1BCRKDRCYP2C9HRH3
SCHEMBL741946 0.89 ABL1 (0.61) ABL1BCRKDRCYP2C9HRH3
SCHEMBL739473 0.89 ABL1 (0.61) ABL1BCRKDRCYP2C9HRH3
SCHEMBL742153 0.89 ABL1 (0.60) ABL1BCRKDRCYP2C9HRH3
SCHEMBL740752 0.88 ABL1 (0.76) ABL1BCRKDRCYP2C9HRH3
SCHEMBL741183 0.88 ABL1 (0.76) ABL1BCRKDRCYP2C9HRH3
SCHEMBL741724 0.88 ABL1 (0.64) ABL1BCRKDRCYP2C9LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed